Nihon Kohden (TYO:6849) announced the U.S. launch of its Life Scope SVM-7200 series vital signs monitor for outpatient facilities and beds that aren’t continuously monitored.
The Life Scope SVM-7200 is designed to provide customizable early warning scoring to help clinicians identify patients who are deteriorating or at risk of deterioration. It combines vital signs data with observational information and can be converted to continuous monitoring mode for viewing vitals within the Nihon Kohden patient monitoring system.
Nihon Kohden’s monitor includes an eight-inch color touch screen display designed for quick clinician navigation, along with non-invasive blood pressure measurement. It offers flexible configuration with Nihon Kohden, Nellcor or Masimo SpO2.
“Our goal is to design monitors that allow clinicians to spend more time with their patients and less time with the technology,” Nihon Kohden America president & CEO Yasuhiro Yoshitake said in a news release. “With the Life Scope SVM-7200, we have fulfilled this promise. It has an elegant, intuitive design that can be patient-ready in a matter of minutes and can be easily moved from room to room as required. Initial user training for the monitor is easy and can be accomplished in less than an hour, and an on-screen tutorial is available whenever needed.”
“Even patients who seem stable can unexpectedly decline,” added Nihon Kohden America VP of clinical and strategic alliances Veffa Devers. “Most will exhibit gradual changes in vital signs hours before they decline, such as a gradual increase in temperature and heart rate or a subtle, yet progressive change in blood pressure and pulse oximetry. These changes can be a signal that a patient is at risk for a larger health concern, such an infection or hemodynamics decline. Regular and consistent monitoring of vital signs combined with our customizable early warning scoring can help clinicians identify these patients early and intervene before the situation becomes critical.”
